메뉴 건너뛰기




Volumn 21, Issue 22, 2011, Pages 6646-6651

7-Oxopyrrolopyridine-derived DPP4 inhibitors - Mitigation of CYP and hERG liabilities via introduction of polar functionalities in the active site

Author keywords

7 Oxopyrrolopyridines; Atropisomers; Diabetes mellitus; DPP4 inhibitors

Indexed keywords

7 OXOPYRROLOPYRIDINE DERIVATIVE; ANTIDIABETIC AGENT; CYTOCHROME P450 3A4; DIPEPTIDYL PEPTIDASE IV; DIPEPTIDYL PEPTIDASE IV INHIBITOR; POTASSIUM CHANNEL HERG; PYRIDINE DERIVATIVE; UNCLASSIFIED DRUG;

EID: 80054734762     PISSN: 0960894X     EISSN: 14643405     Source Type: Journal    
DOI: 10.1016/j.bmcl.2011.09.074     Document Type: Article
Times cited : (20)

References (27)
  • 4
    • 77949285419 scopus 로고    scopus 로고
    • Sitagliptin
    • Sitagliptin: S. Dhillon Drugs 70 2010 489
    • (2010) Drugs , vol.70 , pp. 489
    • Dhillon, S.1
  • 26
    • 84857500501 scopus 로고    scopus 로고
    • 2 (v:v = 3:7) to give (+)-3t in 66% overall yield
    • 2 (v:v = 3:7) to give (+)-3t in 66% overall yield.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.